IMMUCOR INC
CIK:0000736822|SEC Filings
Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | 12 Months Ended | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
Feb. 28, 2017 |
Feb. 29, 2016 |
Feb. 28, 2017 |
Feb. 29, 2016 |
May 31, 2016 |
||||||
| Net sales | $ 93,964 | $ 88,893 | $ 286,233 | $ 281,854 | ||||||
| Cost of sales (*) | [1],[2] | 35,318 | 34,130 | 109,949 | 106,660 | |||||
| Gross profit | 58,646 | 54,763 | 176,284 | 175,194 | ||||||
| Operating expenses: | ||||||||||
| Research and development | 8,828 | 6,910 | 26,625 | 20,500 | ||||||
| Selling and marketing | 13,528 | 13,251 | 44,019 | 42,057 | ||||||
| Distribution | 4,083 | 4,155 | 12,648 | 12,969 | ||||||
| General and administrative | 10,046 | 11,779 | 32,111 | 33,133 | ||||||
| Amortization expense | 14,109 | 13,575 | 42,416 | 40,745 | ||||||
| Total operating expenses | 50,594 | 49,670 | 157,819 | 149,404 | ||||||
| Income from operations | 8,052 | 5,093 | 18,465 | 25,790 | ||||||
| Non-operating income (expense): | ||||||||||
| Interest income | 1 | 48 | 9 | 132 | ||||||
| Interest expense | (22,981) | (22,329) | (69,203) | (67,275) | ||||||
| Other, net | (106) | (317) | (660) | (366) | ||||||
| Total non-operating expense | (23,086) | (22,598) | (69,854) | (67,509) | ||||||
| Loss before income taxes | (15,034) | (17,505) | (51,389) | (41,719) | ||||||
| Benefit for income taxes | (5,616) | (8,845) | (19,112) | (14,046) | ||||||
| Net loss | (9,418) | (8,660) | (32,277) | (27,673) | $ (43,767) | |||||
| Net loss attributable to noncontrolling interest | (1,668) | (237) | (4,654) | (237) | ||||||
| Net loss attributable to shareholders of Immucor, Inc. | (7,750) | (8,423) | (27,623) | (27,436) | ||||||
| Net sales | 93,964 | 88,893 | 286,233 | 281,854 | ||||||
| Cost of sales (*) | [1],[2] | 35,318 | 34,130 | 109,949 | 106,660 | |||||
| Gross profit | $ 58,646 | $ 54,763 | $ 176,284 | $ 175,194 | ||||||
| ||||||||||